{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:18Z","timestamp":1792090578063,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06455-1","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:46:08Z","timestamp":1766407568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive biomarkers in pediatric MASLD: utility of gamma-glutamyltransferase for steatohepatitis and the FIB-4 index for fibrosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Shun","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Sukeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nishimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"6455_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999\u20132014. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"key":"6455_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2024.1576","volume":"178","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liu J, Ni Y, et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2024;178:800\u201313. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.1576.","journal-title":"JAMA Pediatr"},{"key":"6455_CR3","unstructured":"Japan Ministry of Education. Culture, Sports. Science and Technology. 2022 School Health Statistics Results of the Statistics Survey. 2023."},{"key":"6455_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, et al. Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017\u2014Part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33:70\u201385. https:\/\/doi.org\/10.1111\/jgh.13857.","journal-title":"J Gastroenterol Hepatol"},{"key":"6455_CR5","doi-asserted-by":"publisher","first-page":"111136","DOI":"10.1016\/j.intimp.2023.111136","volume":"125","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang J, Xiao S, et al. The impact of liver fibrosis on the progression of hepatocellular carcinoma via a hypoxia-immune-integrated prognostic model. Int Immunopharmacol. 2023;125:111136. https:\/\/doi.org\/10.1016\/j.intimp.2023.111136.","journal-title":"Int Immunopharmacol"},{"key":"6455_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bioactmat.2022.11.001","volume":"23","author":"M Shao","year":"2023","unstructured":"Shao M, Wang Y, Dong H, et al. From liver fibrosis to hepatocarcinogenesis: role of excessive liver H\u2082O\u2082 and targeting nanotherapeutics. Bioact Mater. 2023;23:187\u2013205. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.11.001.","journal-title":"Bioact Mater"},{"key":"6455_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/apt.12518","volume":"38","author":"JB Schwimmer","year":"2013","unstructured":"Schwimmer JB, Newton KP, Awai HI, et al. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38:1267\u201377. https:\/\/doi.org\/10.1111\/apt.12518.","journal-title":"Aliment Pharmacol Ther"},{"key":"6455_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"MB Vos","year":"2017","unstructured":"Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric Gastroenterology, hepatology and nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64:319\u201334. https:\/\/doi.org\/10.1097\/MPG.0000000000001482.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6455_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/jgh.14156","volume":"33","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y, Honda Y, Kessoku T, et al. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type IV collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018;33:1795\u2013803. https:\/\/doi.org\/10.1111\/jgh.14156.","journal-title":"J Gastroenterol Hepatol"},{"key":"6455_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"12","author":"Y Sumida","year":"2012","unstructured":"Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012;12:2. https:\/\/doi.org\/10.1186\/1471-230X-12-2.","journal-title":"BMC Gastroenterol"},{"key":"6455_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatology"},{"key":"6455_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"key":"6455_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u201326. https:\/\/doi.org\/10.1053\/jhep.2003.50346.","journal-title":"Hepatology"},{"key":"6455_CR14","first-page":"797","volume":"64","author":"Y Aizawa","year":"2016","unstructured":"Aizawa Y. [Progress in the management of NAFLD\/NASH]. Rinsho Byori. 2016;64:797\u2013805.","journal-title":"Rinsho Byori"},{"key":"6455_CR15","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/s0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139. https:\/\/doi.org\/10.1016\/s0016-5085(99)70506-8.","journal-title":"Gastroenterology"},{"key":"6455_CR16","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.3748\/wjg.v26.i38.5849","volume":"26","author":"N Gotlieb","year":"2020","unstructured":"Gotlieb N, Schwartz N, Zelber-Sagi S, et al. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World J Gastroenterol. 2020;26:5849\u201362. https:\/\/doi.org\/10.3748\/wjg.v26.i38.5849.","journal-title":"World J Gastroenterol"},{"key":"6455_CR17","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s10620-014-3494-7","volume":"60","author":"S Mansoor","year":"2015","unstructured":"Mansoor S, Yerian L, Kohli R, et al. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci. 2015;60:1440\u20137. https:\/\/doi.org\/10.1007\/s10620-014-3494-7.","journal-title":"Dig Dis Sci"},{"key":"6455_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/MPG.0000000000003919","volume":"77","author":"K Rupasinghe","year":"2023","unstructured":"Rupasinghe K, Hind J, Hegarty R. Updates in metabolic dysfunction-associated fatty liver disease (MAFLD) in children. J Pediatr Gastroenterol Nutr. 2023;77:583\u201391. https:\/\/doi.org\/10.1097\/MPG.0000000000003919.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6455_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/hep.20842","volume":"42","author":"JB Schwimmer","year":"2005","unstructured":"Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641\u20139. https:\/\/doi.org\/10.1002\/hep.20842.","journal-title":"Hepatology"},{"key":"6455_CR20","first-page":"110","volume":"42","author":"H Yokoyama","year":"2007","unstructured":"Yokoyama H. [Gamma Glutamyl transpeptidase (gammaGTP) in the era of metabolic syndrome]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2007;42:110\u201324.","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"6455_CR21","doi-asserted-by":"publisher","unstructured":"Ma Y, Lee G, Heo SY, et al. Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease. Antioxid (Basel). 2021;11. https:\/\/doi.org\/10.3390\/antiox11010091.","DOI":"10.3390\/antiox11010091"},{"key":"6455_CR22","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1053\/j.gastro.2008.08.050","volume":"135","author":"HM Patton","year":"2008","unstructured":"Patton HM, Lavine JE, Van Natta ML, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology. 2008;135:1961\u201371. https:\/\/doi.org\/10.1053\/j.gastro.2008.08.050.","journal-title":"Gastroenterology"},{"key":"6455_CR23","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","volume":"159","author":"SA Xanthakos","year":"2020","unstructured":"Xanthakos SA, Lavine JE, Yates KP, et al. NASH clinical research Network. Progression of fatty liver disease in children receiving standard of care lifestyle advice. Gastroenterology. 2020;159:1731\u201351. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.034.","journal-title":"Gastroenterology"},{"key":"6455_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3138\/canlivj-2023-0023","volume":"26","author":"V Sood","year":"2024","unstructured":"Sood V, Lal BB, Deshmukh A, et al. Breaking boundaries: unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada. Can Liver J. 2024;26:327\u201337. https:\/\/doi.org\/10.3138\/canlivj-2023-0023.","journal-title":"Can Liver J"},{"key":"6455_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease Prevalence, Severity, and outcomes in the united states: A systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:198\u2013210. https:\/\/doi.org\/10.1016\/j.cgh.2017.09.041.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6455_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jpn3.12368","volume":"79","author":"N Ravanbakhsh","year":"2024","unstructured":"Ravanbakhsh N, Browne D, Weaver C, et al. Comparing imaging modalities in the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease. J Pediatr Gastroenterol Nutr. 2024;79:1192\u20138. https:\/\/doi.org\/10.1002\/jpn3.12368.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6455_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jgh3.12349","volume":"4","author":"Y Eguchi","year":"2020","unstructured":"Eguchi Y, Wong G, Lee EI, et al. Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in japan: a focused literature review. JGH Open. 2020;4:808\u201317. https:\/\/doi.org\/10.1002\/jgh3.12349.","journal-title":"JGH Open"},{"issue":"Suppl 1","key":"6455_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","volume":"46","author":"E Hashimoto","year":"2011","unstructured":"Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46(Suppl 1):63\u20139. https:\/\/doi.org\/10.1007\/s00535-010-0311-8.","journal-title":"J Gastroenterol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06455-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:52:37Z","timestamp":1772016757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6455"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06455-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Tokyo Medical University (approval number: T2019-0259). Written informed consent was obtained from all participants and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}